ACST
Acasti Pharma Inc. [ACST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ACST Stock Summary
In the News
ACST Financial details
Company Rating
-
Market Cap
32M
Income
-39.22M
Revenue
-32K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
32
Optionable
No
Shortable
Yes
Earnings
21 Jun 2024
P/E
-0.53
Forward P/E
-
PEG
-0.02
P/S
-838.6
P/B
0.32
P/C
-
P/FCF
-1.74
Quick Ratio
19.93
Current Ratio
20.68
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-5.15
EPS next Y
-
EPS next Q
-
EPS this Y
256.88%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-57.14%
-
-
-
-
SMA20
-4.19%
SMA50
35.02%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-52%
ROE
-55%
ROC
0.22%
Gross Margin
77831%
Oper. Margin
-52950%
Profit Margin
127244%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.72-3.84
52W High
+9.33%
52W Low
+228%
RSI
54.85
Rel Volume
1.24
Avg Volume
28.95K
Volume
36.01K
Perf Week
7.54%
Perf Month
-1.8%
Perf Quarter
-
Perf Half Y
36.1%
-
-
-
-
Beta
1.525
-
-
Volatility
0.07%, 0.14%
Prev Close
1.55%
Price
3.28
Change
0.92%
Company Profile
- Volume Average 28.95K
- Market Capitalization 32M
- Employee 32
- CEO Mr. Prashant Kohli
- Headquarters Laval,QC,CA
- IPO Date 2012-02-07
-
Website
https://www.acastipharma.com 
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
